Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-13 ABERNETHY MATT Chief Financial Officer Grant or award · Restricted Stock Unit +7,735 7,735
2026-02-13 BENEVICH ERIC Chief Commercial Officer Option exercise +1,961 55,639
2026-02-13 BENEVICH ERIC Chief Commercial Officer Shares withheld for taxes −1,058 $124.12 $131K 54,581
2026-02-13 BENEVICH ERIC Chief Commercial Officer Option exercise +2,083 56,664
2026-02-13 BENEVICH ERIC Chief Commercial Officer Shares withheld for taxes −1,124 $124.12 $140K 55,540
2026-02-13 BENEVICH ERIC Chief Commercial Officer Grant or award +16,613 72,153
2026-02-13 BENEVICH ERIC Chief Commercial Officer Shares withheld for taxes −8,963 $124.12 $1.1M 63,190
2026-02-13 BENEVICH ERIC Chief Commercial Officer Option exercise · Restricted Stock Unit −1,961 3,924
2026-02-13 BENEVICH ERIC Chief Commercial Officer Option exercise · Restricted Stock Unit −2,083 2,083
2026-02-13 BENEVICH ERIC Chief Commercial Officer Grant or award · Stock Option +36,287 36,287
2026-02-13 BENEVICH ERIC Chief Commercial Officer Grant or award · Restricted Stock Unit +6,365 6,365
2026-02-13 Gano Kyle Chief Executive Officer Option exercise +2,241 146,254
2026-02-13 Gano Kyle Chief Executive Officer Shares withheld for taxes −1,210 $124.12 $150K 145,044
2026-02-13 Gano Kyle Chief Executive Officer Option exercise +2,566 147,610
2026-02-13 Gano Kyle Chief Executive Officer Shares withheld for taxes −1,385 $124.12 $172K 146,225
2026-02-13 Gano Kyle Chief Executive Officer Grant or award +9,968 156,193
2026-02-13 Gano Kyle Chief Executive Officer Shares withheld for taxes −5,378 $124.12 $668K 150,815
2026-02-13 Gano Kyle Chief Executive Officer Option exercise · Restricted Stock Unit −2,241 4,484
2026-02-13 Gano Kyle Chief Executive Officer Option exercise · Restricted Stock Unit −2,566 2,566
2026-02-13 Gano Kyle Chief Executive Officer Grant or award · Stock Option +114,830 114,830

Page 11 of 49 · 963 trades